Literature DB >> 30302231

Untreated chronic lymphocytic leukemia in Lebanese patients: an observational study using standard karyotyping and FISH.

Elie El Rassy1,1, Alain Chebly2,2, Rima Korban2,2, Warde Semaan2,2, Ziad Bakouny1,1, Tarek Assi1,1, Hampig Raphael Kourie2,2, Fadi El Karak1,1, Eliane Chouery2,2, Joseph Kattan1,1.   

Abstract

AIM: We aimed to understand the biology of chronic lymphocytic leukemia (CLL) patients in Lebanon. MATERIALS &
METHODS: We applied conventional cytogenetic and FISH studies on Lebanese patients diagnosed with CLL and undergoing a watch and wait approach.
RESULTS: Our study disclosed 53.6% of patients with aberrant karyotypes among which 26.7% were complex karyotypes. Genetic aberrations included del(13q14) 46.4%, 14q32 translocation in 25%, trisomy 12 in 14.3%, del(17p13) and del(11q22) in 7.1% each. The deletion of 6q21/6q23 was not found in any of our patients.
CONCLUSION: The higher prevalence of del(13q14) as a sole abnormality could be the primary event in inducing CLL. The del(17p13) and del(11q22) followed as potential drivers for progression in CLL patients with a watch and wait approach.

Entities:  

Keywords:  Middle East; chronic lymphocytic leukemia; fluorescence in situ hybridization; molecular characteristics; small lymphocytic lymphoma

Year:  2017        PMID: 30302231      PMCID: PMC6172003          DOI: 10.2217/ijh-2017-0019

Source DB:  PubMed          Journal:  Int J Hematol Oncol        ISSN: 2045-1393


  24 in total

1.  Revision of the guidelines for diagnosis and therapy of chronic lymphocytic leukemia (CLL).

Authors:  Barbara Eichhorst; Michael Hallek
Journal:  Best Pract Res Clin Haematol       Date:  2007-09       Impact factor: 3.020

2.  Clinico-pathological impact of cytogenetic subgroups in B-cell chronic lymphocytic leukemia: experience from India.

Authors:  P S Kadam Amare; V Gadage; H Jain; S Nikalje; S Manju; N Mittal; S Gujral; R Nair
Journal:  Indian J Cancer       Date:  2013 Jul-Sep       Impact factor: 1.224

3.  A clinical staging system for chronic lymphocytic leukemia: prognostic significance.

Authors:  J L Binet; M Leporrier; G Dighiero; D Charron; P D'Athis; G Vaugier; H M Beral; J C Natali; M Raphael; B Nizet; J Y Follezou
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

4.  Characteristics of Gastric Cancer in Lebanon: a Descriptive Study from a Single Institutional Experience.

Authors:  Tarek Assi; Elie El Rassy; Aline Khazzaka; Tania Moussa; Tony Ibrahim; Clarisse Kattan; Fadi El Karak; Fadi Farhat; Marwan Ghosn; Joseph Kattan
Journal:  J Gastrointest Cancer       Date:  2018-03

Review 5.  The mystery of chronic lymphocytic leukemia (CLL): Why is it absent in Asians and what does this tell us about etiology, pathogenesis and biology?

Authors:  Shen-Miao Yang; Jian-Yong Li; Robert Peter Gale; Xiao-Jun Huang
Journal:  Blood Rev       Date:  2014-12-13       Impact factor: 8.250

Review 6.  Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis.

Authors:  H Döhner; S Stilgenbauer; K Döhner; M Bentz; P Lichter
Journal:  J Mol Med (Berl)       Date:  1999-02       Impact factor: 4.599

7.  Cytogenetic characterisation in Chinese patients with chronic lymphocytic leukemia: a prospective, multicenter study on 143 cases analysed with interphase fluorescence in situ hybridisation.

Authors:  Hong-Xia Qiu; Wei Xu; Xiang-Shan Cao; Min Zhou; Yun-Feng Shen; Yan-Li Xu; Xue-Mei Sun; Qiong Liu; Rong Wang; Hai-Rong Qiu; Ji-Shi Wang; Jian-Yong Li
Journal:  Leuk Lymphoma       Date:  2008-10

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

9.  Prognostic value of PLR in various cancers: a meta-analysis.

Authors:  Xin Zhou; Yiping Du; Zebo Huang; Jun Xu; Tianzhu Qiu; Jian Wang; Tongshan Wang; Wei Zhu; Ping Liu
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

10.  Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions.

Authors:  Anna Puiggros; Rosa Collado; Maria José Calasanz; Margarita Ortega; Neus Ruiz-Xivillé; Alfredo Rivas-Delgado; Elisa Luño; Teresa González; Blanca Navarro; MaDolores García-Malo; Alberto Valiente; José Ángel Hernández; María Teresa Ardanaz; María Ángeles Piñan; María Laura Blanco; María Hernández-Sánchez; Ana Batlle-López; Rocío Salgado; Marta Salido; Ana Ferrer; Pau Abrisqueta; Eva Gimeno; Eugènia Abella; Christelle Ferrá; María José Terol; Francisco Ortuño; Dolors Costa; Carol Moreno; Félix Carbonell; Francesc Bosch; Julio Delgado; Blanca Espinet
Journal:  Oncotarget       Date:  2017-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.